Evidence map›Paper›PMID 36641645›Full record

ArticleAnnals of neurology2023

Bradykinesia and Its Progression Are Related to Interhemispheric Beta Coherence.

Kevin B Wilkins, Yasmine M Kehnemouyi, Matthew N Petrucci, Ross W Anderson, Jordan E Parker, Megan H Trager, Raumin S Neuville, Mandy M Koop, Anca Velisar, Zack Blumenfeld and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effect of frequency on dual target deep brain stimulation.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Deep oscillatory neural network.Scientific reports · 2025
    Article
  7. Closing the loop in DBS: A data-driven approach.Parkinsonism & related disorders · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Kevin B WilkinsDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0001-5907-4029
Yasmine M KehnemouyiDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-0330-5198
Matthew N PetrucciDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0003-3353-2532
Ross W AndersonDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0001-7624-3138
Jordan E ParkerDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0001-9748-7617
Megan H TragerDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-7330-1627
Raumin S NeuvilleDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-5182-7855
Mandy M KoopDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0003-3047-8091
Anca VelisarDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-8349-7782
Zack BlumenfeldDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-4627-5582
Emma J QuinnDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Helen M Bronte-StewartDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0002-1839-4541
Stanford Medicine · USStanford University · USCleveland Clinic · USColumbia University Irving Medical Center · USKaiser Permanente Redwood City Medical Center · USSmith-Kettlewell Eye Research Institute · USUniversity of California, Irvine · USUniversity of California, Los Angeles · USUniversity of Southern California · US

Funding

Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait using Neural and Kinematic FeedbackUH3NS107709 · NINDS · STANFORD UNIVERSITY · PI BRONTE-STEWART, HELEN · 2019 to 2023
$6.1M
Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's diseaseUG3NS128150 · NINDS · STANFORD UNIVERSITY · PI BRONTE-STEWART, HELEN · 2022 to 2023
$2.2M
Biophysical Characterization of Subthalamic Local Field Potentials in Parkinson's DiseaseR01NS119520 · NINDS · DUKE UNIVERSITY · PI MCINTYRE, CAMERON · 2021 to 2024
$1.9M
Neural and Kinematic Features of Freezing of Gait for Adaptive NeurostimulationR21NS096398 · NINDS · STANFORD UNIVERSITY · PI BRONTE-STEWART, HELEN · 2016 to 2017
$432k
NINDS NIH HHS R01 NS119520NINDS NIH HHS R21 NS096398NINDS NIH HHS UG3 NS128150NINDS NIH HHS UH3 NS107709
6 · The paper itself

Abstract

objectiveBradykinesia is the major cardinal motor sign of Parkinson disease (PD), but its neural underpinnings are unclear. The goal of this study was to examine whether changes in bradykinesia following long-term subthalamic nucleus (STN) deep brain stimulation (DBS) are linked to local STN beta (13-30 Hz) dynamics or a wider bilateral network dysfunction.

methodsTwenty-one individuals with PD implanted with sensing neurostimulators (Activa® PC + S, Medtronic, PLC) in the STN participated in a longitudinal 'washout' therapy study every three to 6 months for an average of 3 years. At each visit, participants were withdrawn from medication (12/24/48 hours) and had DBS turned off (>60 minutes) before completing a repetitive wrist-flexion extension task, a validated quantitative assessment of bradykinesia, while local field potentials were recorded. Local STN beta dynamics were investigated via beta power and burst duration, while interhemispheric beta synchrony was assessed with STN-STN beta coherence.

resultsHigher interhemispheric STN beta coherence, but not contralateral beta power or burst duration, was significantly associated with worse bradykinesia. Bradykinesia worsened off therapy over time. Interhemispheric STN-STN beta coherence also increased over time, whereas beta power and burst duration remained stable. The observed change in bradykinesia was related to the change in interhemispheric beta coherence, with greater increases in synchrony associated with further worsening of bradykinesia.

interpretationTogether, these findings implicate interhemispheric beta synchrony as a neural correlate of the progression of bradykinesia following chronic STN DBS. This could imply the existence of a pathological bilateral network contributing to bradykinesia in PD. ANN NEUROL 2023;93:1029-1039.

Indexed as

Deep Brain StimulationParkinson DiseaseSubthalamic NucleusHumansHypokinesia

Identifiers

PMID36641645
PMCPMC10191890
OpenAlexW4316253725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.